{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T05:45:01Z","timestamp":1763963101173,"version":"3.45.0"},"reference-count":39,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background and purpose: Advances in lymphoma treatment lead to a growing population of lymphoma survivors in childbearing ages who might be concerned about the impact of their disease on their children\u2019s health. In this study, we aim to explore healthcare utilisation patterns that were associated with parental history of lymphoma.\nPatients\/material and methods: Children born to lymphoma survivors (diagnosed over the period 2000\u20132018) were identified by linking the Swedish Cancer Register to national population registers. Each child born to a lymphoma survivor was matched on maternal age at childbirth to five children born to lymphoma-free parents. Information on in- and outpatient diagnoses and drug dispensations up to age five were obtained for all children.\nResults: We identified a total of 1,424 children born to lymphoma survivors and 7,120 matched children born to lymphoma-free parents. Children born to lymphoma survivors had a 8% higher healthcare utilisation rate (rate ratio: 1.08, 95% confidence intervals: 1.06\u20131.10) than other children. The panorama of diseases requiring healthcare utilisation was diverse and only one disease (International Classification of Diseases-10: H66, otitis media, unspecified) and one drug cluster (Anatomical Therapeutic Chemical: J07BC20, combination vaccine against hepatitis A and hepatitis B) was associated with a systematic difference (p &lt; 0.05) when applying tree-based scan statistics.\nInterpretation: Children born to lymphoma survivors had slightly increased healthcare utilisation during early childhood. However, no strong or consistent disease- or drug-specific clusters explained this increase. Findings therefore suggest that the elevated healthcare use may reflect heightened health-seeking behaviour among cancer survivors, rather than underlying morbidity in their children. These results provide reassurance for lymphoma survivors considering parenthood.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.43950","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T05:42:37Z","timestamp":1763962957000},"page":"1600-1606","source":"Crossref","is-referenced-by-count":0,"title":["Utilisation of healthcare in children born to lymphoma survivors in Sweden"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1614-8096","authenticated-orcid":false,"given":"Joshua P.","family":"Entrop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Wintzell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline E.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Glimelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarec C.","family":"El-Galaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin E.","family":"Smedby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Eloranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"133690","doi-asserted-by":"crossref","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","DOI":"10.1182\/blood-2016-01-643569"},{"key":"133691","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1182\/blood-2016-01-643569","DOI":"10.1182\/blood-2016-01-643569"},{"key":"133692","unstructured":"Lar\u00f8nningen S, Arvidsson G, Bray F, Dahl-Olsen E, Engholm G, Ervik M, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries: Association of the Nordic Cancer Registries. Cancer Registry of Norway. Version 9.4 (29.08.2024). Association of the Nordic Cancer Registries. Cancer Registry of Norway. Available from: https:\/\/nordcan.iarc.fr\/"},{"key":"133693","unstructured":"Danckert B, Ferlay J, Engholm G, Hansen HL, Johannesen TB, Khan S, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries: Association of the Nordic Cancer Registries [Internet]. Danish Cancer Society. [updated 2019 Mar 26]. Version 8.2. Available from: http:\/\/www.ancr.nu"},{"key":"133694","doi-asserted-by":"crossref","unstructured":"Ekberg S, Smedby KE, Glimelius I, Nilsson-Ehle H, Goldkuhl C, Lewerin C, et al. Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century \u2013 a Swedish lymphoma register study. Br J Haematol. 2020;189(6):1083\u201392.","DOI":"10.1111\/bjh.16489"},{"key":"133695","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjh.16489","DOI":"10.1111\/bjh.16489"},{"key":"133696","doi-asserted-by":"crossref","unstructured":"Nilsson J, Jervaeus A, Lampic C, Eriksson LE, Widmark C, Armuand GM, et al. \u2018Will I be able to have a baby?\u2019 Results from online focus group discussions with childhood cancer survivors in Sweden. Hum Reprod. 2014;29(12):2704\u201311.","DOI":"10.1093\/humrep\/deu280"},{"key":"133697","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/humrep\/deu280","DOI":"10.1093\/humrep\/deu280"},{"key":"133698","doi-asserted-by":"crossref","unstructured":"Harding JE. The nutritional basis of the fetal origins of adult disease. Int J Epidemiol. 2001;30(1):15\u201323.","DOI":"10.1093\/ije\/30.1.15"},{"key":"133699","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/ije\/30.1.15","DOI":"10.1093\/ije\/30.1.15"},{"key":"133700","doi-asserted-by":"crossref","unstructured":"Shliakhtsitsava K, Romero SAD, Dewald SR, Su HI. Pregnancy and child health outcomes in pediatric and young adult leukemia and lymphoma survivors: a systematic review. Leuk Lymphoma. 2018;59(2):381\u201397.","DOI":"10.1080\/10428194.2017.1352097"},{"key":"133701","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/10428194.2017.1352097","DOI":"10.1080\/10428194.2017.1352097"},{"key":"133702","doi-asserted-by":"crossref","unstructured":"Anderson C, Baggett CD, Engel SM, Getahun D, Cannizzaro NT, Mitra S, et al. Risk of adverse birth outcomes after adolescent and young adult cancer. JNCI Cancer Spectr. 2024;8(1):pkad106.","DOI":"10.1093\/jncics\/pkad106"},{"key":"133703","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/jncics\/pkad106","DOI":"10.1093\/jncics\/pkad106"},{"key":"133704","doi-asserted-by":"crossref","unstructured":"Ji J, Huang W, Sundquist J, Sundquist K. Hospitalization rate in offspring of cancer survivors: a national cohort study. J Cancer Surviv. 2019;13(2):187\u201396.","DOI":"10.1007\/s11764-019-00741-5"},{"key":"133705","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s11764-019-00741-5","DOI":"10.1007\/s11764-019-00741-5"},{"key":"133706","doi-asserted-by":"crossref","unstructured":"Ekstrom Smedby K, Eloranta S, Wasterlid T, Falini V, Jerlstrom U, Ellin F, et al. The National Swedish Lymphoma Register \u2013 a systematic validation of data quality. Acta Oncol. 2024;63:563\u201372.","DOI":"10.2340\/1651-226X.2024.40431"},{"key":"133707","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/1651-226X.2024.40431","DOI":"10.2340\/1651-226X.2024.40431"},{"key":"133708","doi-asserted-by":"crossref","unstructured":"Samuelsen SO. A pseudolikelihood approach to analysis of nested case-control studies. Biometrika. 1997;84(2):379\u201394.","DOI":"10.1093\/biomet\/84.2.379"},{"key":"133709","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/biomet\/84.2.379","DOI":"10.1093\/biomet\/84.2.379"},{"key":"133710","unstructured":"Statistics Sweden (SCB). Population by age, sex and year. 2024, Solna, Sweden."},{"key":"133711","doi-asserted-by":"crossref","unstructured":"Fay MP. Two-sided exact tests and matching confidence intervals for discrete data. R J. 2010;2(1):53\u20138.","DOI":"10.32614\/RJ-2010-008"},{"key":"133712","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.32614\/RJ-2010-008","DOI":"10.32614\/RJ-2010-008"},{"key":"133713","doi-asserted-by":"crossref","unstructured":"Cook RJ, Lawless JF. Marginal analysis of recurrent events and a terminating event. Stat Med. 1997;16(8):911\u201324.","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<911::AID-SIM544>3.0.CO;2-I"},{"key":"133714","unstructured":"https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19970430)16:8%3C911::AID-SIM544%3E3.0.CO;2-I"},{"key":"133715","doi-asserted-by":"crossref","unstructured":"Ghosh D, Lin DY. Nonparametric analysis of recurrent events and death. Biometrics. 2000;56(2):554\u201362.","DOI":"10.1111\/j.0006-341X.2000.00554.x"},{"key":"133716","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.0006-341X.2000.00554.x","DOI":"10.1111\/j.0006-341X.2000.00554.x"},{"key":"133717","doi-asserted-by":"crossref","unstructured":"Kulldorff M, Dashevsky I, Avery TR, Chan AK, Davis RL, Graham D, et al. Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013;22(5):517\u201323.","DOI":"10.1002\/pds.3423"},{"key":"133718","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/pds.3423","DOI":"10.1002\/pds.3423"},{"key":"133719","doi-asserted-by":"crossref","unstructured":"Wintzell V, Svanstrom H, Melbye M, Ludvigsson JF, Pasternak B, Kulldorff M. Data mining for adverse events of tumor necrosis factor-alpha inhibitors in pediatric patients: tree-based scan statistic analyses of Danish nationwide health data. Clin Drug Investig. 2020;40(12):1147\u201354.","DOI":"10.1007\/s40261-020-00977-5"},{"key":"133720","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s40261-020-00977-5","DOI":"10.1007\/s40261-020-00977-5"},{"key":"133721","doi-asserted-by":"crossref","unstructured":"Kulldorff M, Fang Z, Walsh SJ. A tree-based scan statistic for database disease surveillance. Biometrics. 2003;59(2):323\u201331.","DOI":"10.1111\/1541-0420.00039"},{"key":"133722","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1541-0420.00039","DOI":"10.1111\/1541-0420.00039"},{"key":"133723","unstructured":"Socialstyrelsen. ICD-10 SE [Internet]. Stockholm: Socialstyrelsen [Accessed March 13, 2024]; Available from: https:\/\/klassifikationer.socialstyrelsen.se"},{"key":"133724","doi-asserted-by":"crossref","unstructured":"Williamson TJ, Stanton AL. Adjustment to life as a cancer survivor. In: Feuerstein M, Nekhlyudov L, editors. Handbook of cancer survivorship. Springer Nature; 2018. p. 29\u201348.","DOI":"10.1007\/978-3-319-77432-9_3"},{"key":"133725","doi-asserted-by":"crossref","unstructured":"Caruso R, Nanni MG, Riba MB, Sabato S, Grassi L. The burden of psychosocial morbidity related to cancer: patient and family issues. Int Rev Psychiatry. 2017;29(5):389\u2013402.","DOI":"10.1080\/09540261.2017.1288090"},{"key":"133726","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/09540261.2017.1288090","DOI":"10.1080\/09540261.2017.1288090"},{"key":"133727","doi-asserted-by":"crossref","unstructured":"Glimelius I, Eloranta S, Ekberg S, Chang ET, Neovius M, Smedby KE. Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy. Am J Hematol. 2017;92(3):251\u20138.","DOI":"10.1002\/ajh.24623"},{"key":"133728","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ajh.24623","DOI":"10.1002\/ajh.24623"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43950\/52093","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/43950\/52093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T05:42:41Z","timestamp":1763962961000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/43950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":39,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.43950","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]}}}